Company Analysis

ADC Therapeutics SA (ADCT)

NYSE: ADCT · Pharmaceutical Preparations · Epalinges, CH · filing with the SEC since 2019
Grade5.3
◀ Past 5.5● Present 4.8▶ Future 6.0
2 est.

Who runs ADC Therapeutics SA

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Mallik Ameet
Chief Executive Officer. First filing Jan 2024, latest Jul 2, 2026, 1 filing in all.
Officers reporting now
5
of 12 people with a filing in the last fifteen months
Directors reporting now
7
14 people on the record since 2024
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Mallik AmeetChief Executive OfficerJan 2024Jul 2, 2026none
Carmona JoseChief Financial OfficerJan 2024Jul 2, 2026none
Graham Peter JChief Legal OfficerJan 2024Jul 2, 2026none
Zaki MohamedChief Medical OfficerJan 2024Jul 2, 2026none
Kallebo Lisa MichelleChief Accounting OfficerJan 2024Feb 18, 2026none
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameRoleFirst filingLatest filingSales, 12 months
Azelby RobertdirectorJan 2024Jun 3, 2026none
Bizzari Jean-PierredirectorJan 2024Jun 3, 2026none
Coughlin TimothydirectorJun 2025Jun 3, 2026none
Hug PeterdirectorJan 2024Jun 3, 2026none
Monges VivianedirectorJan 2024Jun 3, 2026none
Sandor VictordirectorJan 2024Jun 3, 2026none
Squarer RondirectorJan 2024Jun 3, 2026none
Owners of more than 10% of a classsales are open-market, Sep 30, 2025 to Sep 30, 2026
NameRoleFirst filingLatest filingSales, 12 months
Green Jeremy10% ownerFeb 2024Apr 2, 2026none
Redco II Master Fund, L.P.10% ownerFeb 2024Apr 2, 20266 · $19.6M
Redmile Group, LLC10% ownerFeb 2024Apr 2, 2026none
Earlier names on the record3, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton ADCT · research, not advice